Bruker's Microbiology and Infection diagnostics division announces an expansion of its validated Polymerase Chain Reaction (PCR) assays on the BeGenius® sample-to-answer molecular diagnostics system at ESCMID 2025.

Linkam will showcase its new reflected light thermomicroscopy system, the IHS1700, at TAC 2025.

SGD Pharma advances sustainable manufacturing and supply chain innovation at DCAT Week 2025. In recent years, SGD Pharma has committed multi-million-euro investment to modernise its global manufacturing sites.

Leading organizations highlight automation, data quality, and machine learning as efficiency drivers in 2025.

SGD Pharma has been recognized for its decarbonization and sustainability efforts with the prestigious platinum EcoVadis medal for 2025, achieving a score of 87/100.

N4 Pharma Plc (AIM: N4P), the specialist preclinical stage biotech company announces a new lead programme, N4 101.

Linkam's updated CMS196V4 stage features an improved user interface with a touch-panel and joystick, an encoded and motorised XY stage and a newly interchangeable optical bridge for imaging, amongst other updated features.

Nipro PharmaPackaging, a global leader in glass tubing, glass primary packaging, and medical devices, is proud to announce the launch of its innovative D2F™ (Direct-to-Fill) glass vials.

SGD Pharma will showcase its exclusive siliconized molded glass vials as well as its new Type II ready-to-use packaging solution in molded glass, Sterinity EZ-fill ®, at CPHI 2024.

SGD Pharma has completed its first successful campaign using 20 percent post-consumer recycled (PCR) glass. The PCR glass bottles will debut at Luxe Pack Monaco 2024.

Market leader in temperature and environmental-controlled microscopy, Linkam Scientific Instruments, will be presenting its CryoGenium plunger at this year’s Microscopy and Microanalysis conference (M&M) on 28 July – 1 August.

Nipro Medical Corporation proudly announces its significant expansion in the United States with the establishment of its first North American manufacturing facility in Greenville, North Carolina.

SGD Pharma has published its latest annual CSR Report demonstrating its company-wide commitment to a safer and healthier global environment. The Report follows SGD Pharma’s recent achievement of PAI Partners’ prestigious Climate Action Award.

Forensic laboratories around the world are benefitting from the launch of Magritek’s new qIDsolve benchtop NMR software package.

At the start of the year SGD Pharma successfully trialled 100% hydrogen burners for industrial-scale glass production at its Saint-Quentin-Lamotte (SQLM) manufacturing plant in France.

N4 Pharma PLC (AIM: N4P) recently acquired a controlling interest in Nanogenics Limited. Nanogenics has developed a lipid and peptide-based delivery system, LipTide®, which it is using in the formulation of a novel siRNA product – ECP105.

SGD Pharma has achieved a gold EcoVadis Sustainability Rating with an overall score of 77, putting them in the 98th percentile of 125,000 companies.

The new Velocity® Vial offering reduces the frictional resistance created by glass-to-glass and glass-to-metal contact which helps to prevent potential disruptions to the flow of vials, making the fill and finish process 20-50% more efficient.

SGD Pharma has announced the launch of a new siliconization line at its state-of-the-art Saint-Quentin-Lamotte (SQLM) plant. During the siliconization process a layer of silicone is bonded to the internal surface of glass vials.

Fabio Invernizzi has been announced as the new General Manager of SGD Pharma’s West BU. Fabio joins SGD Pharma from Lonza. He aims to bring SGD Pharma to the next level of leadership in the Primary Pharmaceutical Packaging market.

Over the next year, SGD Pharma intends to continue its investment into new ventures, build upon the company’s current efforts towards sustainability and expand its range of glass packaging.

Oz-UK Ltd announces the installation of its new low-GWP manufacturing line to meet global needs for pMDI investigation ahead of the Kigali Amendment deadline.

Following its acquisition of Larix in 2019 and Cmed Group in 2021, Aixial Group has become a leading mid-size, global CRO.

BILLERICA, MA, April 14, 2023 – Bruker Corporation (Nasdaq: BRKR) announces its latest innovations for user-friendly, best-in-class diagnostic solutions for routine clinical microbiology and infection diagnostics laboratories.

Encapsia welcomes new Chief Operating Officer, Francis Destin

Northern Irish company, Sepha, launches new blister packaging machine.

Scitara Corp, a proven innovator in laboratory digital transformation, today announces the closing of its Series B round with an additional investment of $15m.

Leading global pharmaceutical company presented Pangaea Data’s Novel AI to Automatically Generate Textual Clinical Narratives for Regulatory Reports

Sepha has achieved micro leak detection down to one micron (1μm).

Innovative technology for clinical trials is now, more than ever, necessary to deliver decentralized trials (DCT) and enable design of hybrid protocols that support trial continuity and patient-centricity.

AIXIAL GROUP becomes a leading mid-size, worldwide CRO with strong US and European presence and more than 1,000 employees.

Aigenpulse has rolled out an update to its CytoML Experiment Suite – its automated, end-to-end, machine learning solution specifically aimed at streamlining and automating cytometry analysis at scale and replacing manual gating processes.

COVID-19 testing labs can now skip RNA extraction, simplifying and accelerating workflows

Sepha, the Northern Ireland based specialist in pharmaceutical packaging and machinery, has launched a contract packaging service to meet rising demand for small batch production.

Protein Metrics and MOBILion Systems Inc. announce their strategic partnership to provide data analysis modules for Protein Metrics’ Byos software suite that work exclusively with MOBILion’s High-Resolution Ion Mobility Mass Spectrometry System

Sepha, specialist in leak test solutions for the pharmaceutical packaging industry, will be introducing its newly patented 3D Leak Detection technology for pharmaceutical blister packs.

This is the first global installation of its kind to commercially implement this level of high field strength combined with PET

Two applications of the MALDI Biotyper® were recently recognized and published as Official Methods of Analysis SM (OMA) of AOAC INTERNATIONAL.

Magnesium Elektron makes debut with revolutionary bioresorbable alloy solutions and capabilities at upcoming MD&M East 2017 conference